| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.07 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.085 | 0.08 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.08 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.08 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.053 | 0.08 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.08 |